Global WholeHealth Partners Corp (OTCMKTS:GWHP) jumped 8% after announcing five over-the-counter (OTC) products to be available through the Walmart marketplace. The company plans to offer Ovulation, Pregnancy, Glucose, Colorectal Cancer, and Drug Tests in the retail marketplace.
Global WholeHealth Partners, through an EMC2 agreement, will be funded for expansion, sales, and growth. According to the agreement terms, EMC2 might be directed to acquire up to $100 million worth of the company’s shares under agreement for three years in amounts of 100,000 shares that could be increased to 2 million common shares based on the market price. The aggregate shares to be offered through the EMC2 agreement will be around 8.58 million common shares.
The company offers the latest tech employing In-vitro Diagnostic Real-tome PCR machines to detect SARS-CoV-2 IgM/IgG in plasma, whole blood, and human serum. Global WholeHealth Partners has been at the forefront of the fight against vector-borne diseases. So in the coming months, GWPH is a stock to watch.
On Wednesday, GWHP stock went up 8.30% at $0.4656 with more than 191K shares, compared to its average volume of 251k shares. The stock has moved within a range of $0.4375 – 0.4700 after opening the trade at $0.4375.